Biofrontera Inc. (BFRI) Dividend History

Company News

• Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis

  Biofrontera and Almirall have launched the Hats On Challenge, a social media initiative to raise awareness and support for actinic keratosis (AK), a precancerous skin condition. The challenge encourages participants to wear a hat and post on social media to support the work of The Skin Cancer Foundation and Euromelanoma.

  GlobeNewswire Inc.
• Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update

  Biofrontera Inc. reported record total revenues of $37.3 million for 2024, a 9.5% increase from 2023. The company's net loss for 2024 was $17.8 million, an improvement from the $20.1 million loss in 2023. Biofrontera also achieved several key milestones in its clinical development program.

  GlobeNewswire Inc.
• Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

  Biofrontera Inc. reported a 1.5% increase in Q3 2024 revenues, with a 5.6% increase in the first 9 months of 2024. The company faced challenges from Hurricane Milton that delayed shipments, but saw positive uptake of its products and received FDA approval to increase the dosage of Ameluz®.

  GlobeNewswire Inc.
• Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates

  Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 54.55% and 88.87%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: VYGR
• Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates

  Clearside Biomedical (CLSD) delivered earnings and revenue surprises of -21.43% and 76.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: CLSD